CMHC West

May 4-5, 2018

Wynn Las Vegas

Advancing Cardiometabolic Health from East to West

2018 CMHC West Accreditation

May 4-5, 2018 - Las Vegas, NV

Activity Title:

2nd Annual CMHC West

Activity Date

May 4-5, 2018 | Las Vegas, NV

Target Audience

CMHC West is designed for US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.

Statement of Need/Program Overview

The ever-increasing presence of cardiometabolic risk continues to be a major challenge for health care providers in the United States. Current estimates suggest approximately 23% - 38% of all U.S. adults have metabolic syndrome, a constellation of cardiometabolic risk factors, including excessive abdominal fat, insulin resistance, inflammation, dyslipidemia, and hypertension. Patients with multiple cardiometabolic risk factors have twice the likelihood of developing and dying from cardiovascular disease and more than seven times the risk of developing diabetes compared to those with no cardiometabolic risk factors. Cardiovascular disease already affects approximately 83.6 million U.S. adults (> 1 in 3) and is the leading cause of U.S. deaths; however, this CVD burden can be expected to increase.

This sampling of sobering statistics points to a rapidly growing epidemic of cardiovascular and metabolic disease and calls to the forefront the need for medical education focused on all aspects of cardiometabolic risk. The CMHC presents an especially valuable venue for this educational outreach with sessions fostering a collaborative, multidisciplinary approach to care.

The 2018 CMHC West meeting will highlight the latest updates in hypertension, heart failure, diabetes, dyslipidemia, lifestyle management, bariatric surgery, and cardiovascular health, and translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders. This education will be delivered thought provoking educational sessions followed by challenging patient cases The goal is to provide the medical community with evidence-based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Review current and updated evidence-based guideline recommendations for prevention, screening, and treatment of cardiometabolic disease and comorbidities
  • Describe the cardiovascular benefits and risks of bariatric surgery, pharmacotherapy, and lifestyle modifications for weight management in patients with cardiometabolic disease and T2DM
  • Interpret the most recent clinical trial data for the management and treatment of complex patients with hypertension, heart failure, dyslipidemia, and type 2 diabetes mellitus
  • Identify individualized treatment regimens for cardiometabolic diseases based on efficacy and safety of current, new, and emerging pharmacotherapies, benefits of lifestyle modifications, and patient profiles and preferences to optimize patient outcomes

Faculty

Please click here to view all faculty listings.

Program Agenda

Please click here to view the full agenda.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 15 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
There are currently 5.9 pharmacotherapy hours available for this activity. Please continue to check online for updates to these hours.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 15 contact hour(s) (1.5 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Numbers (UAN) are listed below.

Session Title

UAN

Session I: Obesity and Lifestyle Medicine

Bariatric Surgery - State of the Art

0530-9999-18-095-L01-P

What You Need to Know: Complications of Bariatric Surgery

0530-9999-18-096-L01-P

Cardiovascular/Metabolic Benefits of Bariatric Surgery

0530-9999-18-097-L01-P

KEYNOTE PRESENTATION
Obesity and Inflammation: What have we learned from animal models?

0530-9999-18-098-L01-P

Benefits of Physical Activity and Exercise on Cardiovascular and Mental Health

0530-9999-18-099-L01-P

Navigating Weight Loss Management in Diabetic Patients with CV Risk

0530-9999-18-100-L01-P

Session II: Dyslipidemia/Atherosclerosis

Advances in Lipid Therapy: Non-statin Drugs and New Approaches

0530-9999-18-101-L01-P

It’s Time for Consensus: Defining Familial Hypercholesterolemia

0530-9999-18-102-L01-P

Importance of Lifestyle Modifications in Lipid Management

0530-9999-18-103-L01-P

Updates in Severe Hypertriglyceridemia Treatment

0530-9999-18-104-L01-P

Navigating the Diagnosis and Treatment of Hypertriglyceridemia in Patients with High CV Risk

0530-9999-18-105-L01-P

Integrating Evidence-Based Data and Guidelines into Clinical Practice

0530-9999-18-106-L01-P

Challenging Patient Cases: The Triglyceride Dilemma

0530-9999-18-107-L01-P

Session III: Heart Failure and Hypertension

CME BREAKFAST SYMPOSIUM
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

0530-9999-18-108-L01-P

I. Updates in Hypertension: New BP Guidelines from ACC/AHA and ADA

0530-9999-18-109-L01-P

II. Challenging Patient Case: Best Approach to Treatment in Patients with CKD, Hypertension, and T2DM

0530-9999-18-110-L01-P

I. Risk of Heart Failure in Diabetic Patients

0530-9999-18-111-L01-P

II. Challenging Patient Case: Controlling the of Risk Factors for Heart Failure in Patients with Diabetes

0530-9999-18-112-L01-P

I. Approaches to Blood Pressure Control in Heart Failure

0530-9999-18-113-L01-P

II. Integrating BP Control Approaches in A Challenging Heart Failure Patient Case

0530-9999-18-114-L01-P

CME LUNCH SYMPOSIUM
Updates in Inflammation and Secondary CVD Prevention

0530-9999-18-115-L01-P

Session IV: Diabetes Management

Updates on CVOTs: Completed and Ongoing

0530-9999-18-116-L01-P

SGLT2 Inhibitors: MOAs, Benefits, Outcomes, and Class Effect

0530-9999-18-117-L01-P

GLP1 Agonists: MOAs, Benefits, Outcomes, and Differences Between Trials

0530-9999-18-118-L01-P

Combination Therapy to Meet Glycemic Goals

0530-9999-18-119-L01-P

Challenging Patient Cases: Are the Guidelines Still Relevant in 2018?

0530-9999-18-120-L01-P

Dietician Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 15 Continuing Professional Education units (CPEUs) for completion of this activities / materials.
CPE Provider #GE012

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the CMHC Program Evaluation. The CMHC Program Evaluation will be available to complete during the meeting via iPads that will be provided to all attendees. Upon completion of the evaluation, participants will be emailed their CME/CE Certificates within 5-7 business days.

An email link will also be provided after the event, available to those who did not complete the evaluation onsite. All evaluations must be completed by May 31, 2018.

Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed before July 3, 2018.

Fee Information & Refund/Cancellation Policy

There is registration fee for this educational activity, registration information can be found here.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager

Reported Financial Relationship

Ashley Marostica, RN, MSN

Nothing to disclose

Lindsay Borvansky

Nothing to disclose

Andrea Funk

Nothing to disclose

Amanda Turner

Nothing to disclose

Erin Franceschini, MS

Nothing to disclose

Amanda Jamrogiewicz

Nothing to disclose

Karin McAdams

Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Educational Grant Support

The 2018 CMHC West is supported in part by independent and unrestricted educational grants from Amgen and Medtronic. Please continue to check this page for updates.

For educational symposia support please visit this page.

This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.